Moreover, the NicheNetR analysis revealed the potential ligands expressed by C3–4 of LN tumor cells that drive exhausted signatures of CD8 TDYS in RR TFHL, including IL21, TNF, TGFB1, CD80, and CD86 (Fig. S14B–D). This evidence concerns the gene CD86 and neoplasm.